CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 416,598,522
- Total 13F shares
- 127,398,592
- Share change
- +703,946
- Total reported value
- $224,428,220
- Put/Call ratio
- 58%
- Price per share
- $1.76
- Number of holders
- 204
- Value change
- -$819,345
- Number of buys
- 93
- Number of sells
- 79
Quarterly Holders Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 18914F103:
Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivek Garipalli |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
175,554,161
mixed-class rows
|
$525,961,700 | +$998,997 | 07 Jan 2026 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.2%
|
29,813,646
|
$83,180,072 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
23,485,912
|
$55,191,894 | — | 31 Dec 2025 | |
| Chamath Palihapitiya |
3/4/5
|
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner |
—
class O/S missing
|
30,147,610
|
$29,544,657 | — | 07 Jul 2021 | |
| GREENOAKS CAPITAL PARTNERS LLC |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
25,754,556
|
$24,466,828 | — | 22 Nov 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
9,791,208
|
$23,013,307 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
9,320,183
|
$21,902,430 | — | 31 Dec 2025 | |
| Peter J. Kuipers |
3/4/5
|
Chief Financial Officer |
1.4%
|
5,758,353
|
$13,301,795 | — | 29 Jan 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
4,690,904
|
$11,023,623 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
4,491,141
|
$10,554,181 | — | 31 Dec 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.9%
|
3,763,851
|
$8,845,050 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.87%
|
3,634,325
|
$8,541,992 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
3,178,430
|
$7,469,311 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.62%
|
2,599,028
|
$6,107,716 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.56%
|
2,325,253
|
$5,464,345 | — | 31 Dec 2025 | |
| Scott J. Leffler |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,857,303
|
$4,760,157 | — | 25 Jan 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
1,781,239
|
$4,185,911 | — | 31 Dec 2025 | |
| Aric R. Sharp |
3/4/5
|
CEO of Value Based Care |
—
class O/S missing
|
2,100,665
|
$3,907,237 | — | 09 Aug 2024 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
1,315,324
|
$3,091,011 | — | 31 Dec 2025 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
3,093,225
|
$3,031,361 | — | 31 Oct 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
1,172,758
|
$2,755,981 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
1,147,940
|
$2,697,659 | — | 31 Dec 2025 | |
| Joseph R. Martin |
3/4/5
|
General Counsel |
—
class O/S missing
|
2,718,857
|
$2,664,480 | — | 14 Jun 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.26%
|
1,087,975
|
$2,556,741 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
883,536
|
$2,076,310 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.21%
|
863,197
|
$2,028,513 | — | 31 Dec 2025 | |
| Chelsea Clinton |
3/4/5
|
Director |
—
class O/S missing
|
602,814
|
$1,983,258 | — | 06 Jan 2025 | |
| Lee Shapiro |
3/4/5
|
Director |
—
class O/S missing
|
598,622
|
$1,969,466 | — | 06 Jan 2025 | |
| Swiss National Bank |
13F
|
Company |
0.2%
|
828,400
|
$1,946,740 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.19%
|
779,801
|
$1,832,533 | — | 31 Dec 2025 | |
| Soviero Asset Management, LP |
13F
|
Company |
0.18%
|
750,000
|
$1,762,500 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.17%
|
709,482
|
$1,667,282 | — | 31 Dec 2025 | |
| OP Asset Management Ltd |
13F
|
Company |
0.16%
|
655,112
|
$1,539,513 | — | 31 Dec 2025 | |
| IMC-Chicago, LLC |
13F
|
Company |
0.15%
|
642,964
|
$1,510,965 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
637,279
|
$1,497,605 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.15%
|
614,952
|
$1,445,137 | — | 31 Dec 2025 | |
| Demetrios L. Kouzoukas |
3/4/5
|
Director |
0.15%
|
605,980
|
$1,424,174 | — | 06 Jan 2026 | |
| William G. Robinson Jr. |
3/4/5
|
Director |
0.14%
|
597,987
|
$1,405,389 | — | 06 Jan 2026 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
586,497
|
$1,378,268 | — | 31 Dec 2025 | |
| Anna U. Loengard |
3/4/5
|
Director |
0.14%
|
584,666
|
$1,374,081 | +$68,755 | 06 Jan 2026 | |
| Nathaniel S. Turner |
3/4/5
|
Director |
—
class O/S missing
|
1,324,728
|
$1,258,492 | — | 07 Jan 2021 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.13%
|
520,875
|
$1,224,056 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.12%
|
518,970
|
$1,219,580 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
483,390
|
$1,135,960 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
442,460
|
$1,039,780 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
410,900
|
$965,615 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.1%
|
406,970
|
$956,379 | — | 31 Dec 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
400,548
|
$941,288 | — | 31 Dec 2025 | |
| CHOREO, LLC |
13F
|
Company |
0.09%
|
386,922
|
$924,744 | — | 31 Dec 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.09%
|
391,059
|
$918,989 | — | 31 Dec 2025 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q1 2026
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.